Bio-Reference Laboratories (Nasdaq: BRLI) is expected to report Q2 earnings around May 30. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Bio-Reference Laboratories's revenues will expand 7.8% and EPS will expand 24.2%.

The average estimate for revenue is $176.1 million. On the bottom line, the average EPS estimate is $0.41.

Revenue details
 Last quarter, Bio-Reference Laboratories reported revenue of $161.3 million. GAAP reported sales were 16% higher than the prior-year quarter's $138.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, EPS came in at $0.31. GAAP EPS of $0.31 for Q1 were 19% higher than the prior-year quarter's $0.26 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 46.2%, 70 basis points better than the prior-year quarter. Operating margin was 9.8%, 20 basis points better than the prior-year quarter. Net margin was 5.4%, 10 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $711.3 million. The average EPS estimate is $1.78.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 313 members out of 334 rating the stock outperform, and 21 members rating it underperform. Among 103 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 97 give Bio-Reference Laboratories a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bio-Reference Laboratories is outperform, with an average price target of $31.00.

Is Bio-Reference Laboratories the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.